RS63804A - Stable salts of o-acetylsalicylic acid containing basic amino acids ii - Google Patents

Stable salts of o-acetylsalicylic acid containing basic amino acids ii

Info

Publication number
RS63804A
RS63804A YU63804A YUP63804A RS63804A RS 63804 A RS63804 A RS 63804A YU 63804 A YU63804 A YU 63804A YU P63804 A YUP63804 A YU P63804A RS 63804 A RS63804 A RS 63804A
Authority
RS
Serbia
Prior art keywords
amino acids
basic amino
acid containing
acetylsalicylic acid
containing basic
Prior art date
Application number
YU63804A
Other languages
English (en)
Inventor
Felix Ecker
Ralf Bullesbach
Wolfram Ledwoch
Gerhard Franckowiak
Uwe Gessner
Marianne Petersen-Braun
Original Assignee
Bayer Healthcare Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag. filed Critical Bayer Healthcare Ag.
Publication of RS63804A publication Critical patent/RS63804A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)

Abstract

Pronalazak se odnosi na poboljšane kompozicije, sa stabilnim solima o-acetil-salicilne kiseline sa baznim amino kiselinama, na lekove koji ih sadrže, kao i na njihovu upotrebu za pripremanje lekova.
YU63804A 2002-01-18 2003-01-07 Stable salts of o-acetylsalicylic acid containing basic amino acids ii RS63804A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10202019A DE10202019A1 (de) 2002-01-18 2002-01-18 Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II
PCT/EP2003/000059 WO2003059323A2 (de) 2002-01-18 2003-01-07 Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren ii

Publications (1)

Publication Number Publication Date
RS63804A true RS63804A (en) 2006-12-15

Family

ID=7712593

Family Applications (1)

Application Number Title Priority Date Filing Date
YU63804A RS63804A (en) 2002-01-18 2003-01-07 Stable salts of o-acetylsalicylic acid containing basic amino acids ii

Country Status (31)

Country Link
US (1) US20050171070A1 (sr)
EP (1) EP1469835B1 (sr)
JP (1) JP2005519892A (sr)
KR (1) KR20040079936A (sr)
CN (1) CN1298314C (sr)
AR (1) AR038298A1 (sr)
AT (1) ATE378040T1 (sr)
AU (1) AU2003235700B2 (sr)
BR (1) BR0307009A (sr)
CA (1) CA2473893A1 (sr)
CO (1) CO5611102A2 (sr)
CU (1) CU20040161A7 (sr)
DE (2) DE10202019A1 (sr)
EC (1) ECSP045192A (sr)
ES (1) ES2297166T3 (sr)
GT (1) GT200300004A (sr)
HK (1) HK1080371A1 (sr)
HN (1) HN2003000015A (sr)
HR (1) HRP20040742B1 (sr)
IL (1) IL162881A0 (sr)
MX (1) MXPA04006832A (sr)
NO (1) NO20043404L (sr)
NZ (1) NZ534128A (sr)
PE (1) PE20030731A1 (sr)
PL (1) PL370197A1 (sr)
RS (1) RS63804A (sr)
SV (1) SV2004001457A (sr)
TW (1) TWI265810B (sr)
UY (1) UY27612A1 (sr)
WO (1) WO2003059323A2 (sr)
ZA (1) ZA200405533B (sr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004025535A1 (de) * 2004-05-25 2005-12-22 Bayer Healthcare Ag Kombination von Salzen der o-Acetylsalicylsäure und Alpha-Glucosidase-Inhibitoren
DE102005025283A1 (de) 2005-06-02 2006-12-07 Bayer Healthcare Ag Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
DE102005049293A1 (de) * 2005-10-15 2007-04-26 Bayer Healthcare Ag Kombinationspräparate von Salzen oder o-Acetylsalicylsäure
DE102008004386A1 (de) 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
JP5309977B2 (ja) * 2008-12-26 2013-10-09 ライオン株式会社 チュアブル錠
US8173625B2 (en) * 2009-05-08 2012-05-08 Theaprin Pharmaceuticals Inc. Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
EA021588B1 (ru) * 2009-06-25 2015-07-30 Тетра Сиа Бетаиновые соли ацетилсалициловой кислоты
JP5563835B2 (ja) * 2010-01-15 2014-07-30 全星薬品工業株式会社 アスピリン錠剤の製造方法
ITMI20121144A1 (it) * 2012-06-28 2013-12-29 Dipharma Francis Srl Procedimento per la preparazione di un sale di un farmaco antinfiammatorio non steroideo
JP7012725B2 (ja) 2016-12-23 2022-01-28 アスピエアー ゲーエムベーハー アセチルサリチル酸リジン・グリシン粒子の改良された合成
RU2738831C1 (ru) * 2020-03-03 2020-12-17 федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РостГМУ Минздрава России) Способ консервативного лечения невралгии тройничного нерва

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
FR2611501B1 (fr) * 1987-03-04 1991-12-06 Corbiere Jerome Nouvelles compositions pharmaceutiques pour la voie buccale a base d'acetylsalielylate de lysine et leur procede d'obtention
DE10034802A1 (de) * 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren

Also Published As

Publication number Publication date
ATE378040T1 (de) 2007-11-15
UY27612A1 (es) 2003-08-29
JP2005519892A (ja) 2005-07-07
NO20043404L (no) 2004-08-16
CN1298314C (zh) 2007-02-07
AR038298A1 (es) 2005-01-12
WO2003059323A2 (de) 2003-07-24
WO2003059323A3 (de) 2004-03-11
NZ534128A (en) 2005-08-26
IL162881A0 (en) 2005-11-20
BR0307009A (pt) 2004-11-03
DE10202019A1 (de) 2003-07-24
AU2003235700B2 (en) 2007-06-28
CN1642528A (zh) 2005-07-20
CO5611102A2 (es) 2006-02-28
CA2473893A1 (en) 2003-07-24
MXPA04006832A (es) 2004-12-06
EP1469835A2 (de) 2004-10-27
ECSP045192A (es) 2004-08-27
SV2004001457A (es) 2004-05-07
PL370197A1 (en) 2005-05-16
CU20040161A7 (es) 2007-03-23
EP1469835B1 (de) 2007-11-14
AU2003235700A1 (en) 2003-07-30
KR20040079936A (ko) 2004-09-16
ES2297166T3 (es) 2008-05-01
HK1080371A1 (en) 2006-04-28
HRP20040742B1 (en) 2008-05-31
TWI265810B (en) 2006-11-11
HN2003000015A (es) 2003-08-22
ZA200405533B (en) 2005-07-13
GT200300004A (es) 2003-08-22
HRP20040742A2 (en) 2005-08-31
PE20030731A1 (es) 2003-09-22
US20050171070A1 (en) 2005-08-04
DE50308596D1 (de) 2007-12-27
TW200306199A (en) 2003-11-16

Similar Documents

Publication Publication Date Title
MY134521A (en) Stable salts of o-acetylsalicylic acid with basic amino acids
TNSN01108A1 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
MXPA02007819A (es) Sales cristalinas del acido 7-[4-(4-fluorofenil)-6-isopropil-2-[metil(metilsulfonil) amino)pirimidin-5-il)-(3r, 5s)-3, 5-dihidroxihept-6-enoico.
YU57599A (sh) Primena derivata fumarne kiseline
BR0311693A (pt) Sal de formato de o-desmetil-venlafaxina
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
HK1080371A1 (en) Stable salts of o-acetylsalicylic acid containing basic amino acids ii
BR0300709A (pt) Sal de perindopril e as composições farmacêuticas contendo o mesmo
UY26256A1 (es) Amidas de ácidos carboxílicos, medicamentos que contienen estos compuestos, su utilización y su preparación
TW200716138A (en) Stable active compound complex of salts of O-acetylsalicylic acid with basic amino acids and glycine
AU2001246623A1 (en) Molecule of pharmaceutical interest comprising at its N-terminal a glutamic acid or a glutamine in the form of an addition salt to an acid
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
AU2003249868A1 (en) Hair treatment compositions containing xanthine and alpha hydroxy acid
AP2004003094A0 (en) Metabolities of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
HUP0301089A2 (hu) Dermális alkalmazási rendszerek aminolevulinsavhoz
SG165397A1 (en) Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8- aminocaprylic acid
BR0315055A (pt) Diamidas de ácido pirimidin-4,6-dicarboxìilco para a inibição seletiva de colagenases
MXPA05010398A (es) Nuevo metodo para la sintesis del acido (2s)-indolin-2-carboxilico y aplicacion de mismo en la sintesis del perindopril.
TW200505906A (en) Selective mmp-13 inhibitors
ZA200409494B (en) Cosmetic compositions containing salts of malonic acid.
IN2003CH01314A (en) Method for production of D-pantothenic acid and/or salts thereof as adjunct for animal feedstuffs
EP1325918A4 (en) CARDIOUS CELL APOPTOSIS INHIBITORS AND TREATMENT / PREVENTION OF HEART DISEASES
BR0209843A (pt) Processo para a preparação de cilastatina sódica amorfa
AU2003275889A1 (en) Phosphinic acid analogs of glutamate
MXPA04002400A (es) Sales de acidos salicilicos, metodos para su preparacion y su uso como medicamentos.